MedPath

Pilot Study of ONO-1101 in Patients Scheduled for Multi-slice CT

Phase 2
Completed
Conditions
Coronary Artery Disease
Registration Number
NCT00311038
Lead Sponsor
Ono Pharmaceutical Co. Ltd
Brief Summary

The purpose of this study is to evaluate the efficacy and safety of ONO-1101 in patients scheduled for multi-slice CT.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria
  1. 20-74 years old
  2. Heart rate less than 90 beats/min more than 70 beats/min at entering the CT room
Exclusion Criteria
  1. Previous allergic reactions to contrast agent
  2. Renal failure
  3. Asthma
  4. Other exclusion criteria as specified in the protocol

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
heart rate
image quality
safety
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Kanto Region Facility

🇯🇵

Kanto, Japan

Hokuriku Region Facility

🇯🇵

Hokuriku, Japan

Kyusyu Region Facility

🇯🇵

Kyusyu, Japan

© Copyright 2025. All Rights Reserved by MedPath